Correction for Zhang et al., “ Pseudomonas aeruginosa Regulatory Protein AnvM Controls Pathogenicity in Anaerobic Enviro...
...Published in mBio
Erratum for Litschko et al., “A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-...
Published in mBio
Correction for Hu et al., “The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Pro...
Published in Journal of Virology
Correction for Fiore et al., “Inactivation of the Sema5a Gene Results in Embryonic Lethality and Defective Remodeling of...
Published in Molecular and Cellular Biology
mSphere of Influence: 3-D Culture Models Influence Studies on Epstein-Barr Virus Molecular Pathogenesis in the Epitheliu...
Published in mSphere
Kathy Shair works in the field of Epstein-Barr virus (EBV)-associated cancers, with emphasis on nasopharyngeal carcinoma (NPC). In this mSphere of Influence article, she reflects on how the paper “Efficient replication of Epstein-Barr virus in stratified epithelium in vitro ” by Temple et al. (R. M. Temple, J. Zhu, L. Budgeon, N. D. Christensen, et...
Correction for He et al., “MprAB Is a Stress-Responsive Two-Component System That Directly Regulates Expression of Sigma...
Published in Journal of Bacteriology
Correction for Zamorano-Sánchez et al., "Functional Specialization in Vibrio cholerae Diguanylate Cyclases: Distinct Mod...
Published in mBio
Mycosubtilin overproduction by Bacillus subtilis BBG100 enhances the organism's antagonistic and biocontrol activities.
...Published in Applied and environmental microbiology
A Bacillus subtilis derivative was obtained from strain ATCC 6633 by replacement of the native promoter of the mycosubtilin operon by a constitutive promoter originating from the replication gene repU of the Staphylococcus aureus plasmid pUB110. The recombinant strain, designated BBG100, produced up to 15-fold more mycosubtilin than the wild type p...
Erratum for Hernández et al., “Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of...
...Published in Journal of Clinical Microbiology
Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates ...
Published in Antimicrobial Agents and Chemotherapy
Emerging carbapenem resistance in Escherichia coli , including sequence type 131 (ST131), the leading cause of extraintestinal E. coli infections globally, threatens therapeutic efficacy. Accordingly, we determined broth microdilution MICs for three distinctive newer agents, i.e., cefiderocol (CFDC), ceftazidime-avibactam (CZA), and eravacycline (E...
